PLX Interest Expense
Protalix Biotherapeutics Inc · Interest Expense
PLX Interest Expense
Latest reported$1.25Mperiod ending
PLX TTM Interest Expense ($0.00 → $1.25M)
TTM interest expense
High-resolution chart · PNG
PLX interest expense history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Interest Expense (USD) |
|---|---|
| 1,250,000 | |
| 1,539,000 | |
| 1,352,000 | |
| 975,000 | |
| 1,094,000 | |
| 678,000 | |
| 1,062,000 | |
| 1,830,000 | |
| 1,991,000 | |
| 2,929,000 | |
| 3,188,000 | |
| 3,064,000 | |
| 3,243,000 | |
| 2,561,000 | |
| 2,530,000 | |
| 2,788,000 | |
| 4,559,000 | |
| 6,139,000 | |
| 7,677,000 | |
| 9,290,000 | |
| 8,853,000 | |
| 8,598,000 | |
| 9,671,000 | |
| 9,239,000 | |
| 9,316,000 | |
| 9,275,000 | |
| 7,966,000 | |
| 7,738,000 | |
| 7,499,000 | |
| 7,385,000 | |
| 7,685,000 | |
| 9,785,000 | |
| 11,654,000 | |
| 12,906,000 | |
| 12,773,000 | |
| 16,762,000 | |
| 13,992,000 | |
| 11,848,000 | |
| 10,665,000 | |
| 3,645,000 | |
| 3,765,000 | |
| 3,506,000 | |
| 3,759,000 | |
| 4,274,000 | |
| 5,095,000 | |
| 5,327,000 | |
| 5,085,000 | |
| 4,377,000 | |
| 2,657,000 | |
| 1,792,000 | |
| 891,000 | |
| 154,000 | |
| 23,000 | |
| 36,000 | |
| 183,000 | |
| 238,000 | |
| 346,000 | |
| 503,000 | |
| 356,000 | |
| 621,000 | |
| 887,000 | |
| 817,000 | |
| 803,000 | |
| 562,000 | |
| 340,000 | |
| 677,000 | |
| 825,000 | |
| 746,000 | |
| 594,000 | |
| 148,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |